The pathophysiologic hallmark of T2DM is obesity-related loss of insulin potency (peripheral resistance), which leads to an increased insulin-demand that ultimately exceeds the insulin-producing capacity of islet β-cells [6], [7]. The gene discussed is INS; the disease is type 2 diabetes mellitus.